BRPI0507765A - comprimidos revestidos compressos e sua produção - Google Patents

comprimidos revestidos compressos e sua produção

Info

Publication number
BRPI0507765A
BRPI0507765A BRPI0507765-6A BRPI0507765A BRPI0507765A BR PI0507765 A BRPI0507765 A BR PI0507765A BR PI0507765 A BRPI0507765 A BR PI0507765A BR PI0507765 A BRPI0507765 A BR PI0507765A
Authority
BR
Brazil
Prior art keywords
production
coated tablets
tablets
compressed
compressed coated
Prior art date
Application number
BRPI0507765-6A
Other languages
English (en)
Inventor
Craig A Judy
Peter H R Persicaner
Original Assignee
Arrow No 7 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arrow No 7 Ltd filed Critical Arrow No 7 Ltd
Publication of BRPI0507765A publication Critical patent/BRPI0507765A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B30—PRESSES
    • B30B—PRESSES IN GENERAL
    • B30B11/00—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses
    • B30B11/02—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses using a ram exerting pressure on the material in a moulding space
    • B30B11/04—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses using a ram exerting pressure on the material in a moulding space co-operating with a fixed mould
    • B30B11/06—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses using a ram exerting pressure on the material in a moulding space co-operating with a fixed mould each charge of the material being compressed against the previously formed body
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B30—PRESSES
    • B30B—PRESSES IN GENERAL
    • B30B11/00—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses
    • B30B11/34—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses for coating articles, e.g. tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mechanical Engineering (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

COMPRIMIDOS REVESTIDOS COMPRESSOS E SUA PRODUçãO Comprimidos para o tratamento de enxaqueca compreendem um núcleo, contendo o agente ativo sumatriptano ou um sal ou áster seu farmaceuticamente aceitável, e um revestimento, sem sumatriptano. Os comprimidos são preparados pela compressão dos componentes do revestimento, livre do ingrediente ativo, ao redor de um núcleo contendo o ativo parcialmente compresso.
BRPI0507765-6A 2004-02-18 2005-02-15 comprimidos revestidos compressos e sua produção BRPI0507765A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0403628.1A GB0403628D0 (en) 2004-02-18 2004-02-18 Compression-coated tablets and the manufacture thereof
PCT/GB2005/000541 WO2005079763A2 (en) 2004-02-18 2005-02-15 Compression-coated tablets and manufacture thereof

Publications (1)

Publication Number Publication Date
BRPI0507765A true BRPI0507765A (pt) 2007-12-18

Family

ID=32039977

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0507765-6A BRPI0507765A (pt) 2004-02-18 2005-02-15 comprimidos revestidos compressos e sua produção

Country Status (11)

Country Link
US (1) US20070160670A1 (pt)
EP (1) EP1732521A2 (pt)
JP (1) JP2007523140A (pt)
AU (1) AU2005215221B9 (pt)
BR (1) BRPI0507765A (pt)
CA (1) CA2555774A1 (pt)
GB (1) GB0403628D0 (pt)
NO (1) NO20063707L (pt)
NZ (1) NZ549097A (pt)
WO (1) WO2005079763A2 (pt)
ZA (1) ZA200606826B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2970599C (en) * 2013-12-11 2023-01-03 Roland Saur-Brosch Method for the production of a molding
USD941985S1 (en) 2020-04-07 2022-01-25 Nutramax Laboratories, Inc. Dietary supplement
USD941457S1 (en) 2020-04-07 2022-01-18 Nutramax Laboratories, Inc. Dietary supplement
USD942609S1 (en) 2020-08-11 2022-02-01 Nutramax Laboratories, Inc. Dietary supplement
USD941458S1 (en) 2020-08-11 2022-01-18 Nutramax Laboratories, Inc. Dietary supplement

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1210513B (de) * 1962-03-22 1966-02-10 Wilhelm Fette Praez Swerkzeug Verfahren zum Pressen oben offener Huellen aus Huellmasse fuer das Herstellen von Tabletten
EP0181966A1 (en) * 1984-11-13 1986-05-28 Gist-Brocades N.V. Compression-coated dispersible tablets
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
US5082669A (en) * 1989-07-20 1992-01-21 Dainippon Pharmaceutical Co., Ltd. Rapid-releasing oral particle pharmaceutical preparation with unpleasant taste masked
GB9104890D0 (en) * 1991-03-08 1991-04-24 Glaxo Group Ltd Compositions
DE69222006T2 (de) * 1991-10-30 1998-01-22 Glaxo Group Ltd Mehrschichtzusammensetzungen enthaltend Histamin- oder Serotonin- Antagonisten
DK0542364T3 (da) * 1991-11-13 1996-03-11 Glaxo Canada Anordning til reguleret frigivelse
DE19615812A1 (de) * 1996-04-20 1997-10-23 Boehringer Mannheim Gmbh Pharmazeutische Zubereitung enthaltend Diphosphonsäuren zur oralen Applikation
US6740341B1 (en) * 1998-11-25 2004-05-25 Cima Labs Inc. Taste masking rapid release coating system
AT500063A1 (de) * 1999-11-23 2005-10-15 Sandoz Ag Beschichtete tablettenkerne
JP2003116069A (ja) * 2001-08-01 2003-04-18 Sanyo Electric Co Ltd 画像信号処理装置
US7323192B2 (en) * 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
US20040052843A1 (en) * 2001-12-24 2004-03-18 Lerner E. Itzhak Controlled release dosage forms
EP1492508A4 (en) * 2002-03-04 2009-05-06 Teva Pharma DOSAGE FORMS WITH CONTROLLED RELEASE
US20040068000A1 (en) * 2002-10-02 2004-04-08 Mintong Guo Compression coated tablets

Also Published As

Publication number Publication date
NZ549097A (en) 2008-06-30
AU2005215221B9 (en) 2009-10-22
AU2005215221A1 (en) 2005-09-01
US20070160670A1 (en) 2007-07-12
CA2555774A1 (en) 2005-09-01
WO2005079763A2 (en) 2005-09-01
EP1732521A2 (en) 2006-12-20
ZA200606826B (en) 2008-01-08
AU2005215221B2 (en) 2009-06-04
NO20063707L (no) 2006-11-15
WO2005079763A3 (en) 2006-01-05
JP2007523140A (ja) 2007-08-16
GB0403628D0 (en) 2004-03-24

Similar Documents

Publication Publication Date Title
BRPI0409652A (pt) tablete, embalagem farmacêutica, método de tratamento de doenças, e, método de preparação de um tablete
BR0103033A (pt) Partìculas farmacêuticas de sabor mascarado
MXPA05012637A (es) Tableta de liberacion modificada del clorhidrato de bupropion.
EA200501586A1 (ru) Фармацевтические продукты
SE9803772D0 (sv) Pharmaceutical formulation
WO2004012699A3 (en) Modified release composition comprising coated micro matrix particles containing the high soluble active ingredient and a release controlling agent
NO20073073L (no) Farmasoytisk preparat som omfatter et antibiotikum, en triazol og et kortikosteroid
WO2007002597A3 (en) Modified-release formulations of a bupropion salt
WO2006056711A3 (fr) Medicament oral a liberation modifiee d'au moins un principe actif sous forme multimicrocapsulaire
WO2004021968A3 (en) Solution for ungual application
WO2007135193A3 (fr) Forme pharmaceutique orale multimicroparticulaire a liberation prolongee comprenant des moyens anti-mesusage et resistant a l'alcool
WO2005027843A3 (en) Chronotherapeutic dosage forms
GEP20043285B (en) Sustained Release Beadlets Containing Stavudine, Method for Their Production, Pharmaceutical Composition Containing the Same and Use Thereof for Treatment Retroviral Infections
WO2005009410A3 (en) Pharmaceutical compositions having a swellable coating
WO2004071374A3 (en) Once a day orally administered pharmaceutical compositions
BRPI0411623A (pt) forma de dosagem farmacêutica ou dietética, esporopolenina, método para a formação de uma esporopolenina funcionalizada com amina primária ou um outro revestimento de exina, método para a formação de uma esporopolenina funcionalizada com poliamino ou um outro revestimento de exina de um esporo, método para a obtenção de uma esporopolenina funcionalizada com aminoácido ou um outro revestimento de exina de um esporo, esporopolenina funcionalizada ou um outro revestimento de exina de um esporo, forma de dosagem dietética ou flavorizante, método de preenchimento de revestimentos de exina de esporos, uso da forma de dosagem e método de aplicação oral de um ingrediente ativo
EA200600675A1 (ru) Гранулы, содержащие гидрохлорид венлафаксина
AR065342A1 (es) Composiciones farmaceuticas que contienen fumarato de quetiapina
NO20076108L (no) Gelatin-inneholdende topikal sammensetning
WO2005065639A3 (en) Novel pharmaceutical compositions
BRPI0507765A (pt) comprimidos revestidos compressos e sua produção
EP1584335A3 (en) Active substance combination comprising a carbinol composition and an opioid
NO20051463L (no) Inhaleringssammensetninger med hoy legemiddelandel
WO2005079750A3 (en) Films for use as dosage forms
EA200801614A1 (ru) Фармацевтическая композиция, содержащая монтелукаст

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.